Mario Kuttke
Head of Cell Therapy invIOs
Seminars
Wednesday 25th February 2026
EPiC? Manufacturing Platform for Next-Generation CAR Cell Therapies
3:30 pm
- A fully closed cell therapy platform that is clinically validated.
- <6h cell therapy manufacturing enables needle-to-needle times <24h at clinical sites.
- RNA-based, non-viral process allows fast, flexible and repeated dosing.
